Burning Rock Biotech Ltd (BNR) - Dilution Analysis
Visualizing historical and potential share dilution over time
Dilution Analysis
Risk Assessment Details
Summary
BNR currently has 85.1M outstanding shares. with minimal authorized share overhang for future dilution. The company has not diluted shareholders through share issuances in the past 2 years, which is positive for existing holders.
Share Structure Timeline
Historical Data Points
| Date | Event | Outstanding | Supply |
|---|---|---|---|
| Apr 28, 2026 |
20-F filing | 85.1M shares outstanding |
85M | 0 |
| Apr 29, 2025 |
20-F filing | 86.6M shares outstanding |
87M | 0 |
| Apr 29, 2024 |
20-F filing | 86.9M shares outstanding |
87M | 0 |
| Apr 20, 2023 |
20-F filing | 85.3M shares outstanding |
85M | 0 |
| Apr 29, 2022 |
20-F filing | 87.8M shares outstanding |
88M | 0 |
| Apr 29, 2022 |
F-3 filing: This is an F-3 filing for Burning Rock Biotech Limited for the offering of Class A ordinary shares, debt securities, and warrants. |
25M | 0 |
| Mar 23, 2021 |
20-F filing | 25.0M shares outstanding |
25M | 0 |
| Dec 01, 2020 |
F-1 filing: This is an F-1 filing for Burning Rock Biotech Limited indicating an offering of common stock represented by ADSs. |
N/A | 0 |
| May 22, 2020 |
F-1 filing: The company seeks expansion capital to grow its business through the sale of Series C Preferred Shares and issue a warrant to GIC. |
N/A | 0 |